Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-06-020316
Filing Date
2006-03-29
Accepted
2006-03-29 10:33:37
Documents
1
Period of Report
2006-03-28

Document Format Files

Seq Description Document Type Size
1 rrd112630.html 4  
1 rrd112630.xml 4 6413
  Complete submission text file 0001181431-06-020316.txt   8179
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address IMMUCELL CORP 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 2078782770
BRIGHAM MICHAEL F (Reporting) CIK: 0001136544 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12934 | Film No.: 06717077